AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding....
Leadership
Christopher Roberts
CFO & VP of Finance
Piergiorgio Donati
Chief Operating Officer
Martin Zugel M.D., Ph.D.
Interim CEO & Chairman of the Board
Gary Anthony Waanders Ph.D.
Senior VP of Investor Relations & Corporate Communications
Matthias Maurer Ph.D.
Senior VP & General Counsel
Oliver Sol M.D.
VP & Head of Clinical Development
Julien Rongere Ph.D.
Senior Vice President of Regulatory Affairs & Quality Assurance
Mark Danton
Executive Vice President of Information Systems & Artificial Intelligence
